Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis.

Julia SabinElisa SalasJesús Martín-MartínezAntonio Candeliere MerliccoFrancisco Javier Barrero HernándezAna María Alonso TorresJosé Luis Sánchez-MenoyoLaura BorregaMaría Rodríguez-RodríguezMontserrat Gómez-GutiérrezSara EichauMiguel Ángel Hernández-PérezCarmen CallesEva Fernandez-DiazOlga Carmona I Codina Aida OrvizAna López-RealPablo López-MuñozAmelia Mendoza RodríguezEduardo Aguera-MoralesJorge Maurino

Published in: Patient preference and adherence (2024)

Decisional conflict regarding the selection of a disease-modifying therapy was a common phenomenon in patients with mid-stage RRMS. Identifying factors associated with decisional conflict may be useful to implement preventive strategies that help patients better understand their condition and strengthen their self-management resources.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
disease activity
systemic lupus erythematosus
patient reported outcomes
mesenchymal stem cells